5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives
- 1 July 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 33 (7) , 1924-1929
- https://doi.org/10.1021/jm00169a016
Abstract
Note: In lieu of an abstract, this is the article's first page.This publication has 9 references indexed in Scilit:
- Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron)European Journal of Pharmacology, 1989
- The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694British Journal of Cancer, 1988
- Increased gut cholinergic activity and antagonism of 5‐hydroxytryptamine M‐receptors by BRL 24924: potential clinical importance of BRL 24924British Journal of Pharmacology, 1987
- Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonismBritish Journal of Pharmacology, 1986
- Substituted benzamides with conformationally restricted side chains. 1. Quinolizidine derivatives as selective gastric prokinetic agentsJournal of Medicinal Chemistry, 1985
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugsNature, 1985
- [H-3]-LABELED KETANSERIN (R 41 468), A SELECTIVE H-3-LABELED LIGAND FOR SEROTONIN-2 RECEPTOR-BINDING SITES - BINDING-PROPERTIES, BRAIN DISTRIBUTION, AND FUNCTIONAL-ROLE1982
- SEROTONIN AND LYSERGIC-ACID DIETHYLAMIDE BINDING IN RAT-BRAIN MEMBRANES - RELATIONSHIP TO POSTSYNAPTIC SEROTONIN RECEPTORS1976
- SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology and Chemotherapy, 1959